Pregled bibliografske jedinice broj: 190049
Tumor marker CA 125 levels in relation to epithelial ovarian cancer stage
Tumor marker CA 125 levels in relation to epithelial ovarian cancer stage // Collegium antropologicum, 23 (1999), 1; 189-194 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 190049 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Tumor marker CA 125 levels in relation to epithelial ovarian cancer stage
Autori
Fureš, Rajko ; Buković, Damir ; Hodek, Branko ; Klarić, Petar ; Herman, Radoslav ; Grubišić, Goran
Izvornik
Collegium antropologicum (0350-6134) 23
(1999), 1;
189-194
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
CA-125 antigen ; ovarian neoplasms ; carcinoma
Sažetak
The paper deals with 62 ovarian cancer patients observed from 1988 to 1997. Considering the ovarian cancer stage, the patients were divided in two groups. Group I consisted of 31 patients at the early stage of ovarian carcinoma (FIGO classification I and II), while group II oncluded 31 patients with the advanced disease (FIGO classification III and IV). According to FIGO classification, a majory of group I and group II patients was classified as IA (61.3%) and IIIC, respectively. Ovarian carcinoma of the serous pathohistologic type accounting for 48.4% prevailed in both groups, bur there were also endometroid and mucinous types. Sensitivity to CA125 was observed in 93.5% of the group I and in 96.7% of the group II patients. In group I, the mean value of tumor marker CA125 read 262.97 U/ml, median 93 U/ml, ranging from 13-2000 U/ml. In comparison with group I, the mean value of group II tumor marker CA125 was significantly higher reading 1053.81 U/ml, median 365 U/ml, with CA125 levels ranging from 15-9960 U/ml. In relation to patients at the early stage of ovarian cancer, preoperative CA125 serum levels were statistically more significant in the advanced ovarian cancer paients (statistically significant difference p=0.002). When comparing CA125 levels and tumor differentiation according to Broders, no statistically significant difference was observed in both group I(p=0.6144) and group II(p=0.6605). The statistically significant correlation (p=0.00008) was confirmed between advanced ovarian carcinoma and less differentiated tumors (Broders differentiation III and IV).
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Petar Klarić
(autor)
Branko Hodek
(autor)
Rajko Fureš
(autor)
Radoslav Herman
(autor)
Damir Buković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- Index Medicus